BackCorgi ETF Trust I - Corgi Genomics & Precision Medicine ETF Overview
Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF

Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF Return on Equity

Latest ROE for Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF: -80.89% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-80.89%

Return on Equity

-80.89%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF (GNMX) FAQ

Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF (GNMX) currently reports a ROE of -80.89%. That is below the sector sector average of 11.75%. Use the charts on this page to explore Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF's ROE history and peer comparisons.

Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF's ROE of -80.89% is lower than the its sector sector average of 11.75%. That is roughly 788.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF's current -80.89% should be judged against industry norms (sector average: 11.75%) and against GNMX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -80.89%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.75%. From there, open related valuation or income-statement pages for Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF, and consider following GNMX for alerts when major investors trade the stock.